|1.||Tripathi, Madhavi: 4 articles (02/2012 - 04/2011)|
|2.||Jaimini, Abhinav: 3 articles (02/2012 - 10/2011)|
|3.||Sharma, Rajnish: 3 articles (02/2012 - 04/2011)|
|4.||Jain, Jyotika: 2 articles (02/2012 - 04/2011)|
|5.||Bal, Jaspriya: 2 articles (02/2012 - 04/2011)|
|6.||Tamaki, Nagara: 2 articles (01/2012 - 04/2011)|
|7.||Shiga, Tohru: 2 articles (01/2012 - 04/2011)|
|8.||Lee, Dong Soo: 1 article (12/2015)|
|9.||Kang, Keon Wook: 1 article (12/2015)|
|10.||Cheon, Gi Jeong: 1 article (12/2015)|
|1.||Brain Neoplasms (Brain Tumor)
02/01/2012 - "With the availability of multiple positron emission tomography (PET) tracers for neurooncology, there is a need to define the appropriate tracer in a given clinical setting, and it is in this regard that we undertook this study to directly compare F-18 flurodeoxyglucose (FDG) PET and C-11 methionine (MET) PET for the evaluation of recurrence in primary brain tumors. "
07/01/2014 - "Carbon-11 methionine ((11)C-Methionine) is a radio-labeled amino acid currently utilized in Positron Emission Tomography (PET) for imaging primary and metastatic brain tumors. "
02/01/2012 - "Assessment of rhabdoid brain tumor by F-18 FDG PET, C-11 methionine PET and MRI."
02/01/2012 - "Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors."
04/01/2011 - "Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions."
05/01/2002 - "Combination study with PET tracers with higher specificity in tumor diagnosis such as C-11 methionine or F-18 methyltyrosine could be a way to solve this problem."
05/01/1996 - "C-11 Met uptake by the tumor (T) and the contralateral gray matter (NT) was calculated on the PET images. "
03/01/1994 - "Although cancer imaging with PET and C-11 methionine can be performed even in the patient has not fasted, a standardized meal may decrease tumor C-11 methionine uptake."
03/01/1994 - "No substantial change was measured in tumor C-11 methionine influx constants (Ki values). "
11/01/2006 - "To evaluate in brain gliomas the relationship between tumor vascularity measured by MR-based maximum regional cerebral blood volume (rCBV) and tumor amino-acid metabolism based on maximum carbon-11 methionine (MET) uptake on positron emission tomography (PET). "
|3.||Parathyroid Neoplasms (Parathyroid Neoplasm)
03/01/2010 - "We therefore conducted a study to determine the sensitivity of C-11 methionine positron emission tomography/computed tomography (Met-PET/CT) in localizing parathyroid adenomas in pHPT. "
06/01/2013 - "Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT."
12/01/2011 - "To compare the accuracy of planar scintigraphy, single photon emission computed tomography (SPECT), SPECT-CT, and positron emission tomography (PET) with C-11 methionine for the pre-operative detection of parathyroid adenomas. "
12/01/2011 - "Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia."
03/01/2010 - "C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism."
|4.||Neoplasm Metastasis (Metastasis)
02/01/2012 - "F-18 FDG and C-11 methionine PET/CT in intracranial dural metastases."
08/01/2011 - "The aim of the study was the comparison of C-11 methionine (MET) and C-11 choline (CHO) in the positron emission tomography (PET) imaging of brain metastases in correlation to the histopathology findings in stereotactic biopsy. "
08/01/2011 - "Comparison of C-11 methionine and C-11 choline for PET imaging of brain metastases: a prospective pilot study."
07/01/1998 - "The aim of this study was to investigate whether uptake of carbon-11 methionine (MET) is associated with histological grade of malignancy and survival in patients with newly diagnosed or recurrent lymphoma. "
07/01/1998 - "Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas."
01/01/1994 - "Positron emission tomography (PET) with carbon-11 methionine, computed tomography (CT), and magnetic resonance (MR) imaging were performed in 10 patients with histologically verified central nervous system (CNS) lymphoma before and after radiation therapy to compare the radiologic findings and to evaluate the usefulness of PET in monitoring tumor response to radiation therapy. "
01/01/1994 - "Methionine PET clearly depicted CNS lymphoma before radiation therapy as an increased accumulation of C-11 methionine. "
|1.||Choline (Choline Chloride)
|6.||Deoxyglucose (2 Deoxy D glucose)